Roche, Eli Lilly Alzheimer’s Blood Test Cleared In Europe – Eli Lilly (NYSE:LLY), Roche Holding (OTC:RHHB
Roche Wins CE Mark For Alzheimer’s Blood Test Roche said the same high and low cutoff values can…
Roche To Acquire PathAI In Up To $1.05 Billion Deal To Expand Digital Pathology Push – Roche Holding (OTC
Roche (OTC:RHHBY) said Wednesday it will acquire U.S.-based digital pathology and AI company PathAI in a deal worth…
What’s Going On With C4 Therapeutics Stock Thursday? – C4 Therapeutics (NASDAQ:CCCC)
C4 Therapeutics Inc. (NASDAQ:CCCC) shares rose in Thursday’s session after climbing as high as $3.66 in premarket trading.…
Roche’s Obesity Drug Helps Almost 87% People Lose At Least 10% Weight – Roche Holding (OTC:RHHBY)
CT-388 is an investigational once-weekly subcutaneous injectable, dual GLP-1/GIP receptor agonist being developed for the treatment of obesity,…
What’s Going On With Olema Pharmaceuticals Stock On Wednesday? – Olema Pharmaceuticals (NASDAQ:OLMA)
Olema Pharmaceuticals Inc. (NASDAQ:OLMA) stock plunged on Monday as the company navigates recent developments in its clinical trials.…
Roche’s Breast Cancer Drug Falls Short In Phase 3 Study – Roche Holding (OTC:RHHBY)
Roche Holdings AG (OTC:RHHBY) on Monday shared results from the phase 3 persevERA Breast Cancer study of giredestrant…
Roche’s Obesity Drug Shows Promise But Trails GLP-1 Giants Novo Nordisk, Eli Lilly – Roche Holding (OTC:RHHBY)
Genentech on Thursday shared topline results from the Phase 2 ZUPREME-1 trial evaluating petrelintide versus placebo in 493…
White House Readies Drug Price Deals With AbbVie, Novartis, Roche – AbbVie (NYSE:ABBV), Amgen (NASDAQ:AMGN)
AbbVie Inc. (NYSE:ABBV) and several other drugmakers are reportedly expected to announce agreements with the U.S. government on…
Itchy Skin Conditions? Novartis’ Pivotal Trial Success Shows Potential For Targeted Relief – Novartis (NYSE:NVS)
Novartis AG (NYSE:AG) on Wednesday released positive topline results from its pivotal Phase 3 RemIND trial of oral…
Roche To Acquire 89bio For $2.4 Billion In Liver And Cardiometabolic Push – Roche Holding (OTC:RHHBY)
On Thursday, Roche Holdings AG (OTC:RHHBY) agreed to acquire 89bio, Inc. (NASDAQ:ETNB) for $2.4 billion. 89Bio is a…
Why Is Olema Pharmaceuticals Stock Soaring Today? – Olema Pharmaceuticals (NASDAQ:OLMA), Roche Holding (OTC:RHHBY)
The trial evaluated giredestrant as an adjuvant (refers to treatments given after the main treatment) endocrine treatment for…
Roche Sees Steady 2026 Growth As Key Drugs Post Double-Digit Gains – Roche Holding (OTC:RHHBY)
Roche Holdings AG (OTC:RHHBY) reported fiscal 2025 sales of 61.5 billion Swiss Francs (around $76.96 billion), up 7%…